Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype

American Journal of Pathology

Volumn 184, Issue 1, 2014, Pages 271-281

  Ko, Song Yi ^a   Ladanyi, Andras ^b   Lengyel, Ernst ^b   Naora, Honami ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CELL MARKER; INTERLEUKIN 10; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR HOXA9; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; CANCER PROGNOSIS; CELLS; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; OVARY CANCER; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR PROMOTION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES, PERITONEAL; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84890357888     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.09.017     Document Type: Article

References (37)

1. T.D. Tlsty, and L.M. Coussens Tumor stroma and regulation of cancer development Annu Rev Pathol 1 2006 119 150
2. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat Rev Cancer 6 2006 392 401
3. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
4. G. Solinas, G. Germano, A. Mantovani, and P. Allavena Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J Leukoc Biol 86 2009 1065 1073
5. J.W. Pollard Tumor-educated macrophages promote tumor progression and metastasis Nat Rev Cancer 4 2004 71 78
6. H. Naora, and D.J. Montell Ovarian cancer metastasis: integrating insights from disparate model organisms Nat Rev Cancer 5 2005 355 366
7. E. Lengyel Ovarian cancer development and metastasis Am J Pathol 177 2010 1053 1064
8. T. Hagemann, J. Wilson, F. Burke, H. Kulbe, N.F. Li, A. Plüddemann, K. Charles, S. Gordon, and F.R. Balkwill Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype J Immunol 176 2006 5023 5032
9. D. Duluc, Y. Delneste, F. Tan, M.P. Moles, L. Grimaud, J. Lenoir, L. Preisser, I. Anegon, L. Catala, N. Ifrah, P. Descamps, E. Gamelin, H. Gascan, M. Hebbar, and P. Jeannin Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells Blood 110 2007 4319 4330
10. J.C. Pearson, D. Lemons, and W. McGinnis Modulating HOX gene functions during animal body patterning Nat Rev Genet 6 2005 893 904
11. S. Samuel, and H. Naora Homeobox gene expression in cancer: insights from developmental regulation and deregulation Eur J Cancer 41 2005 2428 2437
12. D. Vitiello, P.H. Kodaman, and H.S. Taylor HOX genes in implantation Semin Reprod Med 25 2007 431 436
13. W. Cheng, J. Liu, H. Yoshida, D. Rosen, and H. Naora Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract Nat Med 11 2005 531 537
14. S.Y. Ko, N. Barengo, A. Ladanyi, J.S. Lee, F. Marini, E. Lengyel, and H. Naora HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts J Clin Invest 122 2012 3603 3617
15. K.F. Roby, C.C. Taylor, J.P. Sweetwood, Y. Cheng, J.L. Pace, O. Tawfik, D.L. Persons, P.G. Smith, and P.F. Terranova Development of a syngeneic mouse model for events related to ovarian cancer Carcinogenesis 21 2000 585 591
16. I. Shabo, O. Stai, H. Olsson, S. Doré, and J. Svanvik Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival Int J Cancer 123 2008 780 786
17. J. Pander, M. Heusinkveld, T. van der Straaten, E.S. Jordanova, R. Baak-Pablo, H. Gelderblom, H. Morreau, S.H. van der Burg, H.J. Guchelaar, and T. van Hall Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab Clin Cancer Res 17 2011 5668 5673
18. Q. Zeng, S. Li, D.B. Chepeha, T.J. Giordano, J. Li, H. Zhang, P.J. Polverini, J. Nor, J. Kitajewski, and C.Y. Wang Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling Cancer Cell 8 2005 13 23
19. W. Chen, T. Tang, J. Eastham-Anderson, D. Dunlap, B. Alicke, M. Nannini, S. Gould, R. Yauch, Z. Modrusan, K.J. DuPree, W.C. Darbonne, G. Plowman, F.J. de Sauvage, and C.A. Callahan Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells Proc Natl Acad Sci U S A 108 2011 9589 9594
20. V. Luga, L. Zhang, A.M. Viloria-Petit, A.A. Ogunjimi, M.R. Inanlou, E. Chiu, M. Buchanan, A.N. Hosein, M. Basik, and J.L. Wrana Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration Cell 151 2012 1542 1556
21. A. Muratovska, C. Zhou, S. He, P. Goodyer, and M.R. Eccles Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival Oncogene 22 2003 7989 7997
22. Y. Tan, M. Cheung, J. Pei, C.W. Menges, A.K. Godwin, and J.R. Testa Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling Cancer Res 70 2010 9197 9206
23. B.Q. Trinh, S.Y. Ko, N. Barengo, S.Y. Lin, and H. Naora Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs Cancer Res 73 2013 1000 1010
24. I. Matte, D. Lane, C. Laplante, C. Rancourt, and A. Piché Profiling of cytokines in human epithelial ovarian cancer ascites Am J Cancer Res 2 2012 566 580
25. H. Roca, Z.S. Varsos, S. Sud, M.J. Craig, C. Ying, and K.J. Pienta CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization J Biol Chem 284 2009 34342 34354
26. S.H. Page, E.K. Wright Jr., L. Gama, and J.E. Clements Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP PLoS One 6 2011 e22052
27. P.M. Gilbert, J.K. Mouw, M.A. Unger, J.N. Lakins, M.K. Gbegnon, V.B. Clemmer, M. Benezra, J.D. Licht, N.J. Boudreau, K.K. Tsai, A.L. Welm, M.D. Feldman, B.L. Weber, and V.M. Weaver HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype J Clin Invest 120 2010 1535 1550
28. K. Anton, D. Banerjee, and J. Glod Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion PLoS One 7 2012 e35036
29. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, Y. Zhu, S. Wei, I. Kryczek, B. Daniel, A. Gordon, L. Myers, A. Lackner, M.L. Disis, K.L. Knutson, L. Chen, and W. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949
30. E. Sato, S.H. Olson, J. Ahn, B. Bundy, H. Nishikawa, F. Qian, A.A. Jungbluth, D. Frosina, S. Gnjatic, C. Ambrosone, J. Kepner, T. Odunsi, G. Ritter, S. Lele, Y.T. Chen, H. Ohtani, L.J. Old, and K. Odunsi Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci U S A 102 2005 18538 18543
31. Y. Tone, K. Furuuchi, Y. Kojima, M.L. Tykocinski, M.I. Greene, and M. Tone Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer Nat Immunol 9 2008 194 202
32. Y. Zheng, S. Josefowicz, A. Chaudhry, X.P. Peng, K. Forbush, and A.Y. Rudensky Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate Nature 463 2010 808 812
33. J.T. Jordan, W. Sun, S.F. Hussain, G. DeAngulo, S.S. Prabhu, and A.B. Heimberger Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy Cancer Immunol Immunother 57 2008 123 131
34. M.M. Tiemessen, A.L. Jagger, H.G. Evans, M.J. van Herwijnen, S. John, and L.S. Taams CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages Proc Natl Acad Sci U S A 104 2007 19446 19451
35. G. Jin, H.I. Kawsar, S.A. Hirsch, C. Zeng, X. Jia, Z. Feng, S.K. Ghosh, Q.Y. Zheng, A. Zhou, T.M. McIntyre, and A. Weinberg An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis PLoS One 5 2010 e10993
36. G. Germano, R. Frapolli, C. Belgiovine, A. Anselmo, S. Pesce, M. Liguori, E. Erba, S. Uboldi, M. Zucchetti, F. Pasqualini, M. Nebuloni, N. van Rooijen, R. Mortarini, L. Beltrame, S. Marchini, I. Fuso Nerini, R. Sanfilippo, P.G. Casali, S. Pilotti, C.M. Galmarini, A. Anichini, A. Mantovani, M. D'Incalci, and P. Allavena Role of macrophage targeting in the antitumor activity of trabectedin Cancer Cell 23 2013 249 262
37. E.C. Connolly, J. Freimuth, and R.J. Akhurst Complexities of TGF-β targeted cancer therapy Int J Biol Sci 8 2012 964 978